Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Depreciation & Amortization (CF): 2018-2025

Historic Depreciation & Amortization (CF) for Whitehawk Therapeutics (WHWK) over the last 8 years, with Sep 2025 value amounting to $5,600.

  • Whitehawk Therapeutics' Depreciation & Amortization (CF) fell 88.01% to $5,600 in Q3 2025 from the same period last year, while for Sep 2025 it was $131,900, marking a year-over-year decrease of 30.69%. This contributed to the annual value of $193,000 for FY2024, which is 14.20% up from last year.
  • As of Q3 2025, Whitehawk Therapeutics' Depreciation & Amortization (CF) stood at $5,600, which was down 63.40% from $15,300 recorded in Q2 2025.
  • In the past 5 years, Whitehawk Therapeutics' Depreciation & Amortization (CF) registered a high of $74,000 during Q1 2022, and its lowest value of $2,000 during Q1 2021.
  • For the 3-year period, Whitehawk Therapeutics' Depreciation & Amortization (CF) averaged around $40,655, with its median value being $44,000 (2023).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 3,600.00% in 2022, then tumbled by 88.01% in 2025.
  • Over the past 5 years, Whitehawk Therapeutics' Depreciation & Amortization (CF) (Quarterly) stood at $72,000 in 2021, then tumbled by 36.11% to $46,000 in 2022, then fell by 4.35% to $44,000 in 2023, then climbed by 22.73% to $54,000 in 2024, then slumped by 88.01% to $5,600 in 2025.
  • Its Depreciation & Amortization (CF) was $5,600 in Q3 2025, compared to $15,300 in Q2 2025 and $57,000 in Q1 2025.